Evaluation of the Healthy LifeCheck programme: A vascular risk assessment service for community pharmacies in Leicester city, UK

Journal of Public Health (United Kingdom)

Volumn 35, Issue 3, 2013, Pages 440-446

  Hunt, Benjamin D ^a   Hiles, Stephen L ^a   Chauhan, Avni ^a   Ighofose, Carol ^a   Bharakhada, Nilesh ^a   Jain, Avkash ^a   Davies, Melanie J ^a   Khunti, Kamlesh ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

health services; population based and preventative services; public health

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; FEMALE; HEALTH SERVICE; HUMAN; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PHARMACY; POPULATION-BASED AND PREVENTATIVE SERVICES; PROGRAM EVALUATION; PUBLIC HEALTH; RISK ASSESSMENT; STATISTICS; UNITED KINGDOM; VASCULAR DISEASE;

HEALTH SERVICES; POPULATION-BASED AND PREVENTATIVE SERVICES; PUBLIC HEALTH;

ADULT; AGED; CARDIOVASCULAR DISEASES; ENGLAND; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PHARMACIES; PROGRAM EVALUATION; RISK ASSESSMENT; VASCULAR DISEASES;

EID: 84883479407     PISSN: 17413842     EISSN: 17413850     Source Type: Journal    
DOI: 10.1093/pubmed/fdt017     Document Type: Article

References (33)

1. World Health Organisation. Cardiovascular diseases (CVDs). Fact sheet No. 317. World Health Organisation, 2011. http://www.who. int/mediacentre/ factsheets/fs317/en/index.html (10 January 2013, date last accessed
2. World Health Organisation. Comparative quantification of health risks: Global and regional burden of disease attributable to selected major risk factors. World Health Organisation, 2004. http://www.who.int/healthinfo/global- burden-disease/cra/en/(10 January 2013, date last accessed
3. Bhopal R, Hayes L, White M et al. Ethnic and socio-economic inequalities in coronary heart disease, diabetes and risk factors in Europeans and South Asians. J Public Health Med 2002;24(2):95-105
4. Hart CL, Hole DJ, Smith GD. The contribution of risk factors to stroke differentials, by socioeconomic position in adulthood: The Renfrew/Paisley Study. Am J Public Health 2000;90(11):1788-91
5. Hawkins NM, Jhund PS, McMurray JJ et al. Heart failure and socioeconomic status: Accumulating evidence of inequality. Eur J Heart Fail 2012;14(2):138-46
6. Smith GD, Hart C, Watt G et al. Individual social class, area-based deprivation, cardiovascular disease risk factors, and mortality: The Renfrew and Paisley Study. J Epidemiol Community Health 1998;52(6):399-405
7. Cardio & Vascular Coalition. Cardiovascular disease in England: Opportunities and challenges over the next ten years. Cardio & Vascular Coalition, 2008
8. Lip GY, Barnett AH, Bradbury A et al. Ethnicity and cardiovascular disease prevention in the United Kingdom: A practical approach to management. J Hum Hypertens 2007;21(3):183-211
9. Khunti K, Samani NJ. Coronary heart disease in people of south-Asian origin. Lancet 2004;364(9451):2077-8
10. Department of Health (DoH). Putting prevention first. Vascular checks: Risk assessment and management. Department of Health (DoH), 2008
11. Walker N, Gardiner E, Davies M et al. The NHS Health Checks programme: Implications for delivery in primary care. Diabetes & Primary Care 2009;11(4):209-215
12. Khunti K, Hiles S, Davies M. Reducing the impact of vascular disease: The proposed Vascular Risk Programme for risk assessment and management. PCCJ 2008;1(2):72-76
13. British Cardiac S, British Hypertension S, Diabetes UK et al. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005;91(Suppl. 5):v1-52
14. Horgan JM, Blenkinsopp A, McManus RJ. Evaluation of a cardiovascular disease opportunistic risk assessment pilot ('Heart MOT' service) in community pharmacies. J PublicHealth (Oxf) 2010;32(1):110-6
15. Peterson GM, Fitzmaurice KD, Kruup H et al. Cardiovascular risk screening program in Australian community pharmacies. Pharm World Sci 2010;32(3):373-80
16. Dabrera G, Pinson D, Whiteman S. Chlamydia screening by community pharmacists: A qualitative study. J Fam Plann Reprod Health Care 2011;37(1):17-21
17. Crealey GE, McElnay JC, Maguire TA et al. Costs and effects associated with a community pharmacy-based smoking-cessation programme. Pharmacoeconomics 1998;14(3):323-33
18. Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med 2003;25(2):144-53
19. Department of Health. Pharmacy in England. Building on strengths-delivering the future. Department of Health, 2008. http://www.official-documents.gov.uk/document/cm73/7341/7341.pdf (10 January 2013, date last accessed
20. 2001 Census: Standard area statistics (England and Wales). http://www.census.ac.uk/(10 January 2013, date last accessed
21. The English Indices of Deprivation 2010. Communities and local government, 2011
22. Race for Health. Profile: Leicester City PCT [03/04/2012]. http://www.raceforhealth.org/members/pcts/leicester-city. (10 January 2013, date last accessed
23. D'Agostino RB Sr., Vasan RS, Pencina MJ et al. General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation 2008;117(6):743-53
24. Department of Health. A vision for pharmacy in the new NHS. Department of Health, 2003. http://www.dh.gov.uk/prod-consum- dh/groups/dh-digitalassets/@dh/ @en/documents/digitalasset/dh- 4068356.pdf (10 January 2013, date last accessed
25. National Public Health Service for Wales. Vascular risk assessment by community pharmacists. National Public Health Service for Wales, 2009
26. Department of Health. Vascular checks: Risk assessment and management: 'Next Steps' Guidance for Primary Care Trusts. Department of Health, 2008. http://www.dh.gov.uk/prod-consum-dh/groups/dh- digitalassets/@dh/@en/documents/ digitalasset/dh-090278.pdf (10 January 2013, date last accessed
27. Department of Health. The gender and access to health services study final report. Department of Health, 2008. http://www.dh. gov.uk/prod-consum-dh/ groups/dh-digitalassets/@dh/@en/documents/digitalasset/dh-092041.pdf (10 January 2013, date last accessed
28. Free C, McKee M. The new NHS: From specialist services to special groups. Meeting the needs of black and minority ethnic groups. BMJ 1998;316(7128):380
29. UK National Screening Committee. The Handbook for Vascular Risk Assessment, Risk Reduction and Risk Management. UK National Screening Committee, 2008. http://www.screening.nhs.uk/getdata. php?id=14339 (10 January 2013, date last accessed
30. Bhopal R, Unwin N, White M et al. Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: Cross sectional study. BMJ 1999;319(7204):215-20
31. Cappuccio FP, Cooj DG, Atkinson RW et al. The Wadsworth Heart and Stroke Study. A population-based survey of cardiovascular risk factors in different ethnic groups. Methods and baseline findings. Nutr Metab Cardiovasc Dis 1998;8:372-385
32. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991;337(8738):382-6
33. Williams R, Bhopal R, Hunt K. Health of a Punjabi ethnic minority in Glasgow: A comparison with the general population. J Epidemiol Community Health 1993;47(2):96-102